Prescription drug · ANDA
Metronidazole NDC 70518-3110
Metronidazole 500 mg/1 · Tablet · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-3110-5 | 7051831100570518311005 | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3110-5)Marketed from Sep 30, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metronidazole
- Generic name (nonproprietary)
- metronidazole
- Active ingredients
- Metronidazole — 500 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203974
- Marketing start
- Listing expires
- Other FDA classes
- Nitroimidazoles (Chemical structure)
- Identifiers
- Product ID 70518-3110_583a453f-8970-dbb4-e063-6394a90a2f50SPL ID 583a453f-8970-dbb4-e063-6394a90a2f50SPL set ID dc28753c-95ec-4b41-ad77-c4a66698d9dbRxCUI 311681UNII 140QMO216E
- Pharmacologic class
- Nitroimidazole Antimicrobial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518311005followed by a unit qualifier and the quantityPackage 70518-3110-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Symptomatic Trichomoniasis. Metronidazole tablets are indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). Asymptomatic Trichomoniasis. Metronidazole tablets are indicated in the treatment of asymptomatic T. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. Since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. Treatme…
Excerpt only. Read the full label for complete information.
About NDC 70518-3110
- What is NDC 70518-3110?
- 70518-3110 is the product NDC for Metronidazole, Metronidazole 500 mg/1 tablet, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Metronidazole.
- What is the active ingredient?
- Metronidazole.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Metronidazole?
- 160 other product NDCs are listed under this name. See all Metronidazole NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Metronidazole products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Metronidazole | Metronidazole 500 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4767 | 70518-4767-00 |
| Metronidazole | Metronidazole 250 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-024 | 85742-0024-2485742-0024-25 |
| Metronidazole | Metronidazole 500 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-025 | 85742-0025-2485742-0025-25 |
| Metronidazole | Metronidazole 250 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2677 | 72162-2677-0172162-2677-0272162-2677-05 |
| Metronidazole | Metronidazole 500 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2678 | 72162-2678-0172162-2678-0272162-2678-05 |
| Metronidazole | Metronidazole 500 mg/1 | Tablet, Film coatedOral | Coupler LLC | 67046-1060 | 67046-1060-03 |
| Metronidazole | Metronidazole 500 mg/1 | Tablet, Film coatedOral | Coupler LLC | 67046-1173 | 67046-1173-03 |
| Metronidazole | Metronidazole 7.5 mg/g | GelTopical | Zydus Lifesciences Limited | 70771-1978 | 70771-1978-04 |
| Metronidazole | Metronidazole 7.5 mg/g | GelTopical | Viona Pharmaceuticals Inc | 72578-209 | 72578-0209-04 |
| Metronidazole | Metronidazole 7.5 mg/g | GelVaginal | Solaris Pharma Corporation | 73473-303 | 73473-0303-70 |
Other NDCs under ANDA 203974
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metronidazole | Metronidazole 500 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-664 |
| Metronidazole | Metronidazole 250 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-665 |
| Metronidazole | Metronidazole 250 mg/1 | TabletOral | A-S Medication Solutions | 50090-5691 |
| Metronidazole | Metronidazole 250 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-694 |
| Metronidazole | Metronidazole 500 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-695 |
| Metronidazole | Metronidazole 500 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-2399 |
| Metronidazole | Metronidazole 250 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1838 |
| Metronidazole | Metronidazole 500 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1922 |